Literature DB >> 22684150

Eliciting patients' preferences for outpatient treatment of febrile neutropenia: a discrete choice experiment.

Nina Lathia1, Pierre K Isogai, Scott E Walker, Carlo De Angelis, Matthew C Cheung, Jeffrey S Hoch, Nicole Mittmann.   

Abstract

BACKGROUND: Studies have demonstrated that patients at low risk for febrile neutropenia (FN) complications can be treated safely and effectively at home. Information on patient preferences for outpatient treatment of this condition will help to optimize health care delivery to these patients. The purpose of this study was to elicit non-Hodgkin lymphoma patients' preferences on attributes related to outpatient treatment of FN.
METHODS: We used a self-administered discrete choice experiment questionnaire based on the attributes of out-of-pocket costs, unpaid caregiver time required daily, and probability of return to the hospital. Ten paired scenarios in which levels of the attributes were varied were presented to study patients. For each pair, patients indicated the scenario they preferred. Adjusted odds ratios (ORs) of accepting a scenario that described outpatient care for FN were estimated.
RESULTS: Eighty-eight patients completed the questionnaire. Adjusted ORs [95 % confidence intervals] of accepting outpatient care for FN were 0.84 [0.75, 0.95] for each $10 increase in out-of-pocket cost; 0.82 [0.68, 0.99] for each 1 h increase in daily unpaid caregiver time; and 0.53 [0.50, 0.57] for each 5 % increase in probability of return to the hospital.
CONCLUSIONS: Probability of return to the hospital was the most important attribute to patients when considering home-based care for FN. Patients considered out-of-pocket costs and unpaid caregiver time to be less important than probability of return to the hospital. This study identifies factors that could be incorporated into outpatient delivery systems for FN care to ensure adequate patient uptake and satisfaction with such programs.

Entities:  

Mesh:

Year:  2012        PMID: 22684150     DOI: 10.1007/s00520-012-1517-5

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  20 in total

1.  Preference measurement using conjoint methods: an empirical investigation of reliability.

Authors:  S Bryan; L Gold; R Sheldon; M Buxton
Journal:  Health Econ       Date:  2000-07       Impact factor: 3.046

2.  Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules.

Authors:  Kenneth V I Rolston; Ellen F Manzullo; Linda S Elting; Susan E Frisbee-Hume; Leslie McMahon; Richard L Theriault; Shreyaskumar Patel; Robert S Benjamin
Journal:  Cancer       Date:  2006-06-01       Impact factor: 6.860

3.  Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing.

Authors:  Kathryn A Phillips; Tara Maddala; F Reed Johnson
Journal:  Health Serv Res       Date:  2002-12       Impact factor: 3.402

4.  The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone.

Authors:  Toshiro Mizuno; Noriyuki Katsumata; Hirofumi Mukai; Chikako Shimizu; Masashi Ando; Toru Watanabe
Journal:  Support Care Cancer       Date:  2006-08-29       Impact factor: 3.603

5.  Economic analyses of toxicity secondary to anthracycline-based breast cancer chemotherapy.

Authors:  G Dranitsaris; T M Tran
Journal:  Eur J Cancer       Date:  1995-12       Impact factor: 9.162

6.  Methodological issues in the monetary valuation of benefits in healthcare.

Authors:  Mandy Ryan; Verity Watson; Mabelle Amaya-Amaya
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2003-12       Impact factor: 2.217

7.  Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

Authors:  Nicole M Kuderer; David C Dale; Jeffrey Crawford; Leon E Cosler; Gary H Lyman
Journal:  Cancer       Date:  2006-05-15       Impact factor: 6.860

8.  Patient preferences for managing asthma: results from a discrete choice experiment.

Authors:  Madeleine T King; Jane Hall; Emily Lancsar; Denzil Fiebig; Ishrat Hossain; Jordan Louviere; Helen K Reddel; Christine R Jenkins
Journal:  Health Econ       Date:  2007-07       Impact factor: 3.046

9.  Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.

Authors:  Charles L Bennett; Elizabeth A Calhoun
Journal:  Oncologist       Date:  2007-04

10.  Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.

Authors:  Helen Innes; Sheow Lei Lim; Allison Hall; Su Yin Chan; Neeraj Bhalla; Ernest Marshall
Journal:  Support Care Cancer       Date:  2007-09-25       Impact factor: 3.603

View more
  6 in total

Review 1.  Risk as an attribute in discrete choice experiments: a systematic review of the literature.

Authors:  Mark Harrison; Dan Rigby; Caroline Vass; Terry Flynn; Jordan Louviere; Katherine Payne
Journal:  Patient       Date:  2014       Impact factor: 3.883

2.  A Systematic Review of Discrete Choice Experiments in Oncology Treatments.

Authors:  Hannah Collacott; Vikas Soekhai; Caitlin Thomas; Anne Brooks; Ella Brookes; Rachel Lo; Sarah Mulnick; Sebastian Heidenreich
Journal:  Patient       Date:  2021-05-05       Impact factor: 3.883

3.  Patient preferences for hospital quality: case study of iran.

Authors:  Yasser Jouyani; Mina Bahrampour; Mohsen Barouni; Reza Dehnavieh
Journal:  Iran Red Crescent Med J       Date:  2013-09-01       Impact factor: 0.611

4.  Discrete Choice Experiments in Health Economics: Past, Present and Future.

Authors:  Vikas Soekhai; Esther W de Bekker-Grob; Alan R Ellis; Caroline M Vass
Journal:  Pharmacoeconomics       Date:  2019-02       Impact factor: 4.981

5.  A Comparative Study on Willingness to Pay for Breast Cancer and Osteoporosis Screening in Kerman, Southeastern Iran.

Authors:  Asma Sabermahani; Sedighe Mohammad Taghizade; Reza Goodarzi
Journal:  Iran J Public Health       Date:  2017-05       Impact factor: 1.429

6.  Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial.

Authors:  Caroline Forde; Ronan McMullan; Mike Clarke; Richard H Wilson; Ruth Plummer; Margaret Grayson; Cliona McDowell; Ashley Agus; Annmarie Doran; Danny F McAuley; Anne L Thomas; Rosemary A Barnes; Richard Adams; Ian Chau; Vicky Coyle
Journal:  Trials       Date:  2020-05-27       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.